25.03.2013 - Swiss Cytos Biotechnology Ltd (Schlieren) has strengthened its Board with two appointments.
Matthias Alder will become Executive Vice President for Corporate Development and Legal Affairs and Cheryl Lassen will follow Philipp Mueller as Vice President for Clinical Development, who will retire at the end of March 2013. Matthias Alder brings in more than 19 years of experience in the pharmaceutical and biotechnology sector. He comes in from Micromet, where he was Senior VP Administration, General Counsel and Secretary. Previousy he worked with Cooley LLP, as in-house counsel at Ciba-Geigy and Novartis. Cheryl Lassen, MD, joins bringing a wealth of clinical development experience, with particular expertise in respiratory diseases. Dr. Lassen joins Cytos from Novartis where she was Program Leader. In her 20 year career, she has worked on a multitude of clinical development programs and in medical affairs in the UK and in South Africa for companies including Bristol Myers Squibb, Abbott Laboratories and Pharmacia.http://www.european-biotechnology-news.com/people/bio-people/2013-01/cheryl-lassen.html